Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

21
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
21
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

32
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
32
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

201
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
201
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

3.5K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.5K
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

21
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
21
Hazard Ratio01:12

Hazard Ratio

299
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
299

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing a Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease in a Diverse Cohort.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Predicting Psychiatric Readmission of Children and Adolescents Using Machine Learning.

Journal of child and adolescent psychopharmacology·2026
Same author

GWAS analysis of a depression cohort defined by an EHR-phenotyping algorithm reveals the role of immune regulations in depression risk.

Frontiers in genetics·2026
Same author

Identifying anaphylaxis using weakly-supervised prediction models and natural language processing.

medRxiv : the preprint server for health sciences·2026
Same author

Unsupervised characterization of 100,272 EHR patients identifies high-risk groups and comorbidities linked to premature aging.

NPJ digital medicine·2026
Same author

Evaluating the feasibility of the CIPHER metadata framework towards building a conceptual phenotype standard.

JAMIA open·2026

Related Experiment Video

Updated: Oct 19, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K

An updated, computable MEDication-Indication resource for biomedical research.

Neil S Zheng1,2, V Eric Kerchberger1,3, Victor A Borza4

  • 1Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.

Scientific Reports
|September 24, 2021
PubMed
Summary
This summary is machine-generated.

The updated MEDication-Indication (MEDI) knowledgebase (MEDI-2) significantly expands medication and indication data for electronic health records research. MEDI-2 offers improved recall and precision, enhancing its utility for modern healthcare applications.

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

758

Related Experiment Videos

Last Updated: Oct 19, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

758

Area of Science:

  • Biomedical Informatics
  • Computational Linguistics
  • Pharmacology

Background:

  • The MEDication-Indication (MEDI) knowledgebase, established in 2013, has been instrumental in electronic health record (EHR) research.
  • Continuous updates in drug information and terminology necessitate a revised knowledgebase for contemporary EHR systems.
  • The original MEDI version required enhancement to incorporate the latest pharmaceutical data and nomenclature.

Purpose of the Study:

  • To rebuild and update the MEDication-Indication (MEDI) knowledgebase for improved compatibility with modern electronic health records (EHRs).
  • To enhance the comprehensiveness and accuracy of medication-indication relationships.
  • To evaluate the performance of the updated MEDI knowledgebase against its predecessor.

Main Methods:

  • Extracted medication-indication data using natural language processing and ontology relationships from six diverse public resources: RxNorm, Side Effect Resource 4.1, Mayo Clinic, WebMD, MedlinePlus, and Wikipedia.
  • Developed an updated knowledgebase, MEDI-2, incorporating new drugs and terminology.
  • Compared MEDI-2 against the previous version (MEDI-1) using manual review to assess precision and recall metrics.

Main Results:

  • MEDI-2 encompasses 3031 medications and 186,064 indications, a substantial increase over MEDI-1.
  • MEDI-2 demonstrated improved recall (0.89 vs. 0.79) while maintaining precision (0.60) compared to MEDI-1.
  • The MEDI-2 high precision subset (HPS) showed enhanced recall (0.65 vs. 0.55) with equivalent precision (0.92).

Conclusions:

  • The rebuilt MEDI-2 knowledgebase provides a more comprehensive and accurate resource for medication-indication information.
  • MEDI-2 significantly improves upon MEDI-1 in terms of data volume and recall, making it more valuable for EHR research.
  • The updated MEDI knowledgebase is poised to facilitate advanced applications and research within the evolving landscape of digital health.